| Lipid nanoparticle (LNP) enables mRNA delivery for cancer therapy Y Zong, Y Lin, T Wei, Q Cheng Advanced Materials 35 (51), 2303261, 2023 | 161 | 2023 |
| Non-viral delivery of the CRISPR/Cas system: DNA versus RNA versus RNP Y Lin, E Wagner, U Lächelt Biomaterials Science 10 (5), 1166-1192, 2022 | 89 | 2022 |
| Enhanced anticancer efficacy of paclitaxel through multistage tumor-targeting liposomes modified with RGD and KLA peptides J Sun, L Jiang, Y Lin, EM Gerhard, X Jiang, L Li, J Yang, Z Gu International journal of nanomedicine, 1517-1537, 2017 | 76 | 2017 |
| Delivery of Cas9/sgRNA ribonucleoprotein complexes via hydroxystearyl oligoamino amides J Kuhn, Y Lin, A Krhac Levacic, N Al Danaf, L Peng, M Höhn, DC Lamb, ... Bioconjugate Chemistry 31 (3), 729-742, 2020 | 46 | 2020 |
| Folate receptor‐mediated delivery of Cas9 RNP for enhanced immune checkpoint disruption in cancer cells Y Lin, U Wilk, J Pöhmerer, E Hörterer, M Höhn, X Luo, H Mai, E Wagner, ... Small 19 (2), 2205318, 2023 | 40 | 2023 |
| Chemical evolution of amphiphilic xenopeptides for potentiated Cas9 ribonucleoprotein delivery Y Lin, X Luo, T Burghardt, S Dorrer, M Höhn, E Wagner, U Lächelt Journal of the American Chemical Society 145 (28), 15171-15179, 2023 | 20 | 2023 |
| Redox/ATP switchable theranostic nanoparticles for real-time fluorescence monitoring of doxorubicin delivery Y Lin, Y Yang, J Yan, J Chen, J Cao, Y Pu, L Li, B He Journal of Materials Chemistry B 6 (14), 2089-2103, 2018 | 20 | 2018 |
| Co-delivery of doxorubicin and itraconazole by Pluronic® P123 coated liposomes to enhance the anticancer effect in breast cancers Y Lin, X He, D Zhou, L Li, J Sun, X Jiang RSC advances 8 (42), 23768-23779, 2018 | 16 | 2018 |
| Receptor-targeted dual pH-triggered intracellular protein transfer M Lyu, M Yazdi, Y Lin, M Höhn, U Lächelt, E Wagner ACS Biomaterials Science & Engineering 10 (1), 99-114, 2022 | 10 | 2022 |
| Surface engineering of lipid nanoparticles: targeted nucleic acid delivery and beyond Y Lin, Q Cheng, T Wei Biophysics Reports 9 (5), 255, 2023 | 8 | 2023 |
| Biomimetic mineralization of iron-fumarate nanoparticles for protective encapsulation and intracellular delivery of proteins N Mirzazadeh Dizaji, Y Lin, T Bein, E Wagner, S Wuttke, U Lächelt, ... Chemistry of Materials 34 (19), 8684-8693, 2022 | 8 | 2022 |
| Chemical-electron-transfer-based lipopolyplexes for enhanced siRNA delivery F Zhang, Y Lin, M Höhn, E Wagner Cell Reports Physical Science 4 (6), 2023 | 5 | 2023 |
| mCherry on Top: A Positive Read-Out Cellular Platform for Screening DMD Exon Skipping Xenopeptide–PMO Conjugates AL Lessl, J Pöhmerer, Y Lin, U Wilk, M Höhn, E Hörterer, E Wagner, ... Bioconjugate Chemistry 34 (12), 2263-2274, 2023 | 4 | 2023 |
| Spleen-Targeted mRNA Vaccine Doped with Manganese Adjuvant for Robust Anticancer Immunity In Vivo Z Luo, Y Lin, Y Meng, M Li, H Ren, H Shi, Q Cheng, T Wei ACS nano 18 (44), 30701-30715, 2024 | 3 | 2024 |
| Bacterial and cancerous cell membrane fused liposome coordinates with PD-L1 inhibitor for cancer immunotherapy X Luo, C Li, Z Guo, H Wang, P He, Y Zhao, Y Lin, C He, Y Hou, Y Zhang, ... Nano Research 17 (9), 8389-8401, 2024 | 2 | 2024 |
| Iron-gallic acid peptide nanoparticles as a versatile platform for cellular delivery with synergistic ROS enhancement effect F Shen, Y Lin, M Höhn, X Luo, M Döblinger, E Wagner, U Lächelt Pharmaceutics 15 (7), 1789, 2023 | 2 | 2023 |
| Dual pH-responsive CRISPR/Cas9 ribonucleoprotein xenopeptide complexes for genome editing X Luo, J Germer, T Burghardt, M Grau, Y Lin, M Höhn, U Lächelt, ... European Journal of Pharmaceutical Sciences 205, 106983, 2025 | | 2025 |
| Receptor-specific delivery of Cas9 ribonucleoprotein for cancer therapy Y Lin lmu, 2022 | | 2022 |
| Folate-targeted Cas9/sgRNA Ribonucleoprotein Delivery for Dual Immune Checkpoints Disruption in Colorectal Carcinoma Y Lin, E Wagner, U Laechelt HUMAN GENE THERAPY 32 (19-20), A71-A71, 2021 | | 2021 |
Ernst WagnerProfessor, Ludwig-Maximilians-Universität (LMU) München確認したメール アドレス: cup.uni-muenchen.de